The Clorox Company (NYSE:CLX) Shares Bought by Victory Capital Management Inc.

Victory Capital Management Inc. lifted its stake in shares of The Clorox Company (NYSE:CLX) by 12.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 363,554 shares of the company’s stock after purchasing an additional 39,942 shares during the period. Victory Capital Management Inc. owned 0.29% of Clorox worth $59,045,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also made changes to their positions in the stock. State Street Corp lifted its position in Clorox by 3.1% during the third quarter. State Street Corp now owns 8,182,109 shares of the company’s stock worth $1,332,947,000 after buying an additional 245,525 shares in the last quarter. Mizuho Securities USA LLC increased its stake in shares of Clorox by 46,877.8% in the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock worth $733,095,000 after acquiring an additional 4,490,421 shares during the last quarter. Geode Capital Management LLC raised its holdings in shares of Clorox by 1.1% during the 3rd quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock worth $491,713,000 after acquiring an additional 33,970 shares during the period. Stifel Financial Corp boosted its position in shares of Clorox by 1.7% during the 3rd quarter. Stifel Financial Corp now owns 2,334,826 shares of the company’s stock valued at $380,370,000 after acquiring an additional 37,967 shares during the last quarter. Finally, FMR LLC grew its holdings in shares of Clorox by 27.6% in the third quarter. FMR LLC now owns 776,232 shares of the company’s stock valued at $126,456,000 after purchasing an additional 168,111 shares during the period. 78.53% of the stock is currently owned by institutional investors and hedge funds.

Clorox Stock Up 1.8 %

Shares of NYSE:CLX opened at $151.11 on Friday. The firm has a market capitalization of $18.61 billion, a PE ratio of 41.29, a price-to-earnings-growth ratio of 2.62 and a beta of 0.42. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 20.52, a current ratio of 0.94 and a quick ratio of 0.60. The firm’s 50-day moving average is $155.65 and its two-hundred day moving average is $160.34.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, topping the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the business posted $2.16 earnings per share. Analysts predict that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. The ex-dividend date is Wednesday, April 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.23%. Clorox’s payout ratio is 133.33%.

Analysts Set New Price Targets

Several equities analysts have weighed in on CLX shares. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Barclays upped their price objective on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. DA Davidson cut their target price on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research note on Wednesday, February 5th. Royal Bank of Canada restated a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Finally, JPMorgan Chase & Co. increased their price target on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $159.62.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.